Cristina Csimma

Cristina Csimma currently serves as the Executive Chair of the Board of Directors at Sardona Therapeutics since March 2024 and as a Non-Executive Director at Syncona Limited since February 2022. Extensive experience includes roles at the National Institutes of Health overseeing NeuroNext and the Blueprint Neurotherapeutics Network, as well as serving on the Scientific Advisory Board for the Muscular Dystrophy Association and the TREAT-NMD Advisory Committee for Therapeutics. Between April 2019 and December 2023, Cristina Csimma chaired the Board of Directors at Caraway Therapeutics, Inc. and held positions on the boards of various companies, including Idera Pharmaceuticals and Forendo Pharma Ltd. Educational credentials include a BS in Pharmacy and PharmD from the Massachusetts College of Pharmacy and Health Sciences and an MHP in Research Methodology from Northeastern University.